Member Info for JustHereForHemo

HT your life must be really sad to spend so much time dedicated to being as negative as possible on here.

Every single placing on the London stock exchange is a "dirty deal". If your rich you can use your money to make alot more money, the system sucks, it's not fair. Dry your eyes. Atleast for once our SP didn't tank, it's sunny outside, go take a walk and stop being so bitter.

How can we answer? Unless it's one of us any answer is a guess. So here are several possible GUESSES assuming it was the placee:

1, He wants to get below 3%

2 He wanted the warrants and was willing to agree no discount, take a small loss to secure 1 for 1 warrants and did not intend to hold.

3, He didn't even have 500k and got broker to front most of it and had no choice.

4, it's someone entirely different, we have been waiting for years, maybe the shares belong to joe Bloggs and he died and his family liquidated his estate.

Bottom line is why ask us because NONE OF US KNOW. But atleast know we know why it has not moved in 2 days despite massive buying. Was it the placee? MAYBE, and if it was that's 1/3 of his shares cleared.

Day 14 today or yesterday:

https://www.lse.co.uk/rns/HEMO/second-patient-treated-with-hg-ct-1-car-t-therapy-5ualyv3u83r2j8h.html

That means as per https://clinicaltrials.gov/study/NCT06786533?spons=hemogenyx&rank=1

Day 14 is first point of measuring "efficacy of HG-CT-1 cells as defined by clinical response according to established criteria for AML."

We are also approaching 3month marker for P1.

SP might not be reflecting these facts but the trial for HG-CT-1 is progressing and is now in full swing with results positive enough that they have expanded into paediatrics. Trolls can try and spread FUD but all they want to do is make you forget about the facts. We are on a timeline, the trial moves on, no amount of trash talk on LSE can stop the clock.

Going to repeat this here because it needs to be said. Hemo wanted to start with paediatrics, they didn't because the FDA required testing on adults first to prove safety and efficacy.

The amendments made today to the IND follow the same process, 30 days to object or sooner if they wish.

After that it's not "Conditional approval" after approval they can start including children IMMEDIATELY. They may not be in a position to, the point is the FDA will have been satisfied.

The submission MUST meet the FDA requirements.

So?? It's increasingly obvious HG-CT-1 works. People can argue as much as they want that we have not seen the results but it's turning into a really stupid argument at this point. HG-CT-1 works and is safe to the point that MDA and Hemogenyx believe they have enough to satisfy the FDA.

Some people are going to disagree, normally I would temper my language to try and limit the arguments, but nope. Not here. This RNS is evidence of an FDA submission that PROVES that so far HG-CT-1 is working.

The lack of rise is not due to lack of buying its due to an over supply of shares. I wish I could tell you exactly how many are left, but I don't know. But plain and simple the lack of rise is the massive number of shares dumped on that 40% discount shafting. When it clears we will move because people ARE buying. Tomorrow? Next week? Later? Idk

Micky, I can give you a valid response if you want one?

There was an excellent update on P1 treated, following that approx 500-600k of buying which was sold into by the Market Maker (Yes confirmed, yes I rang them, yes they were selling and yes it was naked shorting and illegal)

Due to the 40% discount they ended up with about 50% of their shares going to close off shorts with the MM and the remainder ALMOST free shares, basically costing them 100kish.

The 40% slvt drop was marked down on open which meant that every leverage position under the sun was wiped out dumping ALOT of stock on the MMs along with traders and angry LTHers.

That is ALOT of stock at 180p and below with no real sentiment attached basically sitting on MM books.

THAT is why the SP does not drop, the MMs DO NOT WANT TO TAKE A LOSS they dont drop the SP because they wont sell at a loss and dont want to buy either. BUT the numbers 2 months on are at the point where we could realistically be about to clear that overhang despite ALOT of buying.

But as Pigu says data is being shared behind the scenes and that includes big pharma. I am however thrilled to see people starting to use AI to cut out the BS as they should, everything posted on LSE from EVERYONE including mysefl should be disregarded by everyone and people should use whats in RNS's and available via opensource to generate valuations and future predictions based on stage of trials, likelyhood of success etc and rely on that and not what any of us post on here! Enough people do that and the likes of Stu become completely powerless.

BBB, I would actually be fine with your predictions to be fair however I would make some alterations:

The delay between patient 1 and 2 was patient specific, perhaps it was a blood infection that had to be cleared before they took another sample... it could happen again but more likely than not it wont, the company would have treated much sooner and are aiming for one patient per month for cohort 1 and one patient every 2-3 weeks for cohort 2. If I was being optimistic I would say patient 3 treated end of May, but probably week 1 of June, using 8 weeks skews the results implying another delay which is possible but < 50:50.

Once the spacing drops to 14 days then its much easier to maintain that cadence as you can prepare patients in parallel so your AI prediction is entirely reasonable.

I would also say that your timeline assumes Vlad is happy to just carry on with only HG-CT-1 trials and would be willing to wait 5-6 months to secure enough funds to pick up CDX and CBR..... I assure you that is not the case, you should make sure your AI is aware of the other platforms Hemogenyx have and the need to fund them sooner rather than later.

I dont know about the Journal paper but I do know the clinical trial outline specifies results at 6 months so there should be SOME results made available in July/August.

Stu, I am not going to waste time on a point by point with you, the 95% IND approval was quoted from metrics provided by the FDA which I provided. You really hate the SP going up dont you?

Cba changing my reply:

LOL. You have literally been decimated by 2 different AIs that have looked at your posts and Haywains posts, why the F would any of us bother to waste OUR time?

https://x.com/i/grok/share/cP7o2S9GXUHxtLmRJYehiYh1l

JRDC your entitled to your opinion, but saying what is possible is irrelevant, whats likely is more important.

1, No they cannot raise £5m spread over 12 months with a 25% discount. You offer a discount the SP moves to that price and means more dilution requiring alot more shares. Basically they would have to do an EGM to keep authorising allocations AND every placing would require a prospectus. So no it does not work. The loop hole that they found going via the directors allocation DOES work and could be used again HOWEVER that does not work well with the placees who want discount due to their requirement to satisfy MMs of availability of shares prior to naked shorting, it does work with no discount placings with warrants as we saw last week.

2, 5m would not fund Hemogenyx for 12 months, point blank, as they accelerate to 2 patients per month they will need more than 5m a year AND right now CDX and CBR are not being developed due to conservation of cash efforts. Categorically Vlad is NOT going to just float along for 12 months doing just one patient a month and letting CBR and CDX get dusty. I BELIEVE (No I have not been told) that the company will seek to raise 10-20m+ in the coming months and THAT comes from big pharma/VC/JV etc as it simply cannot be raised via placings when your mCap is 7m.

3, RR AML is the holy grail, its incredibly hard to treat hence the lack of options, if progress continues to be positive we are not going to struggle to find buyers. 3-5 years is utter BS, if you believe that then go do some research, but there is no excuse for being ignorant in this day and age, EVERYONE has access to AI, fact check yourself before posting.

Would like to expand on what HFH said:

"One thing I know for sure, Vlad said they would not progress with treating children with HG-CT-1 until the hospital were 100% sure it was safe."

In the various interviews and zooms etc with Vlad he has said there are conditions and they are not allowed to progress to paediatrics until Anderson are happy the adult cohort is safe AND effective.

Lets be clear before Stu starts piping in... We do not know the numbers, we have not seen a single scientific paper, we will not see a report until month 6. HOWEVER that does not mean there are no reports, no metrics or test results. Patient 1 is now month 3, bone marrow samples have been taken. Patient 2 has been treated approx 2 weeks ago and tested daily. WE dont know the results but the hospital do and THEY are the ones who have had to green light submission of the FDA amendment to Hemogenyx and they say yes.

Anyone who comes on trying to point out the obvious that YES its still possible it may not work well enough in enough patients to be approved, that IS possible, but its also just as possible that WW3 will kick off and we will all be killed (TBH IMO still a reasonable chance of that between Russia/Ukraine or China/Taiwan). Certain individuals trying to inflate the risk and downside when currently NOTHING is priced in except compete utter failure.

Hemogenyx WOULD NOT have released the RNS today unless MD Anderson were happy and gave them the OK. End of story. Its not about what I think or Vlad thinks. Right now MDAnderson are running the trials with Prevail and Hemogenyx are the supplier. A FANTASTIC update that says this shiz works AND hopefully very soon works on kids

Pingu, I actually suspect he MIGHT have told the truth here:

"I’m neither long or short here"

He knows the potential so IMO he normally does hold shares, he is quiet when he is holding (or using his many other profiles).

So he could very well have dumped his load this morning for a trade and be hoping to buy back cheaper. Now woud be a great time for an RNS vlad.... ;-) if ALL the sells are hid and I'm being very generous... it means he usually holds what??? 15k max lol???? All that effort for that??? Get a life stu, take your money and go find a better investment with less risk and better potential.

Cba changing my reply:

LOL. You have literally been decimated by 2 different AIs that have looked at your posts and Haywains posts, why the F would any of us bother to waste OUR time?

https://x.com/i/grok/share/cP7o2S9GXUHxtLmRJYehiYh1l

You went balls deep this morning didnt you lol!!! How many of those sells were yours???? God this is gold!

LOL. You have literally been decimated by 2 different AIs that have looked at your posts and Haywains posts, why the F would any of us bother to waste OUR time?

https://x.com/i/grok/share/cP7o2S9GXUHxtLmRJYehiYh1l

You went balls deep this morning didnt you lol!!! How many of those sells were yours???? God this is gold!

Are you an idiot???? Why on gods green earth would I call out that the AGM was authorising 400 MILLION shares on a public forum when there are trolls like yourself, Stu and TW lurking about? Are you really that thick?????? Your the one that likes to just beach and moan on LSE and attack the company. I noticed an error and reached out to the company, got clarity, they issued a correction and end of story. On what planet is it a good idea to instead of doing that just going on LSE to moan about it?? MAYBE if I had wanted to short or trade I would have. Seriously???? Like Seriously??? Do you think before you type?

Oh 100% pharma is risky which is why there is always a significant discount at each phase of development, pre IND 9 out of 10 fail, the discount on market cap often trades 95%. Phase 1 failure rate into phase 2 is actually very low with a 70-80% success rate:

https://x.com/i/grok/share/2XKQDupnx5zKSMd7zvVj9a5zB

Which means the discounted rate is much less than in pre-IND, at a 7mil mCap? Total and absolute failure is priced in, fair market value is considerably higher as you well know.

You want to criticise the science? Or the value? YES LETS DO IT!!

But lets take OUR egos out of it. Lets let the AI do the work:

Question: what is the success rate of clinical trials in phase 1 going into phase 2 for CAR-T treatments in particular around oncology?

https://x.com/i/grok/share/2XKQDupnx5zKSMd7zvVj9a5zB

Ok..... This one is golden. I am not going to be replying to you any more directly, Grok will be answering you, sorry but I am out skilled and irrelevant after this one:

https://x.com/i/grok?conversation=1922215507073368360

Worth pointing out this is the ANNUAL GM, vs the EGM which was held simply to authorise shares, this is to cover the next 12 months and the company clearly want to avoid EGMs in future as they are unwanted distractions, costs and delays.

So WHY ask for 100%?

Because the company is valued at 7m. If they are talking to a big pharma today they can say they can raise enough with the authority to self fund for a year.

The can issue shares for placings - We saw a non discount placing last week, I would welcome these if needed, no discount + warrants is a position of stability.

Or if they have a VC looking to invest and want a percentage of Hemo and not just HG-CT-1 - They need to issue shares

Or if they secure a JV with a pharma who takes a stake in Hemo - They need to issue shares.

Clearly a few have jumped on this CLARIFICATION email which corrects an error to have a quick trade, probably a early short, Stu is back for a trade I see, but NOTHING has changed in the past few days, nada, zilch, just a REDUCTION in the number of shares they can issue. Its obvious who sold/shorted, they clearly were not that observant as they totally missed the original authority was for 10000% dilution!!! Well let them try their trade, if they are short let them take the risk, they clearly dont know much if they are reacting to todays RNS and think its something new.

Welcome back Stu. good luck with your short, one of us is going to get burnt ;-)

So I'm the only one who read the original rns??? And now you moan? That's classic.

They issued that RNS because I called out the error in the original one, so why exactly would I have to spin anything? I ASKED for this clarification RNS. Last year they had 30% and an EGM for 50% and never used it. This does NOT exempt them from requiring a prospectus if they wish to breach 20%.

I'm a shareholder, I'd rather posters on here focus on what matters and what attracts additional inward investment, ie the science. You post for your ego, your personal grudges and seeking petty point scoring because that's more important to you than ant possible investment you may have. But again I'll answer you, Hemogenyx and the CEO have literally ZERO responsibility for enforcement of a TR1 being issued. And the placee themselves? There will guaranteed be zero punishment if they opt not to file one. But they might, I don't know, you don't know and yet your going to fill that void from now until 48hrs after the shares are listed with irrelevant posts that you KNOW are not going to be answered by the company, but you will post anyway. Atleast on the other site I don't have to see your posts, but here? The fact remains it's not about just empty idol bs snipping posts. This is the ONLY place new investors find, as shareholders we should all want less of this utter bs pointless carp and more discussion on trials, science, progress, future funding routes etc.